Impact and cost-effectiveness of SARS-CoV-2 self-testing strategies in schools: a multicountry modelling analysis.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
27 Feb 2024
Historique:
medline: 1 3 2024
pubmed: 29 2 2024
entrez: 28 2 2024
Statut: epublish

Résumé

To determine the most epidemiologically effective and cost-effective school-based SARS-CoV-2 antigen-detection rapid diagnostic test (Ag-RDT) self-testing strategies among teachers and students. Mathematical modelling and economic evaluation. Simulated school and community populations were parameterised to Brazil, Georgia and Zambia, with SARS-CoV-2 self-testing strategies targeted to teachers and students in primary and secondary schools under varying epidemic conditions. SARS-CoV-2 Ag-RDT self-testing strategies for only teachers or teachers and students-only symptomatically or symptomatically and asymptomatically at 5%, 10%, 40% or 100% of schools at varying frequencies. Outcomes were assessed in terms of total infections and symptomatic days among teachers and students, as well as total infections and deaths within the community under the intervention compared with baseline. The incremental cost-effectiveness ratios (ICERs) were calculated for infections prevented among teachers and students. With respect to both the reduction in infections and total cost, symptomatic testing of all teachers and students appears to be the most cost-effective strategy. Symptomatic testing can prevent up to 69·3%, 64·5% and 75·5% of school infections in Brazil, Georgia and Zambia, respectively, depending on the epidemic conditions, with additional reductions in community infections. ICERs for symptomatic testing range from US$2 to US$19 per additional school infection averted as compared with symptomatic testing of teachers alone. Symptomatic testing of teachers and students has the potential to cost-effectively reduce a substantial number of school and community infections.

Identifiants

pubmed: 38417953
pii: bmjopen-2023-078674
doi: 10.1136/bmjopen-2023-078674
pmc: PMC10900377
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e078674

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

CMAJ Open. 2022 Dec 6;10(4):E1027-E1033
pubmed: 36622324
BMJ. 2022 Mar 9;376:e069761
pubmed: 35264324
Lancet. 2021 Oct 2;398(10307):1217-1229
pubmed: 34534517
Nat Genet. 2023 Jan;55(1):26-33
pubmed: 36624344
BMJ Glob Health. 2021 Jul;6(Suppl 4):
pubmed: 34275874
JAMA Netw Open. 2023 Feb 1;6(2):e2255599
pubmed: 36790812
Global Health. 2022 Jan 22;18(1):5
pubmed: 35065670
J Sch Health. 2022 May;92(5):445-451
pubmed: 35156210
BMC Public Health. 2021 Jan 12;21(1):125
pubmed: 33430832
Nat Commun. 2022 Mar 1;13(1):1106
pubmed: 35232987
Lancet Child Adolesc Health. 2021 Jun;5(6):428-436
pubmed: 33751952
PLoS Med. 2021 Aug 12;18(8):e1003735
pubmed: 34383750
Elife. 2022 Nov 16;11:
pubmed: 36383192
Elife. 2022 Jul 05;11:
pubmed: 35787310
EClinicalMedicine. 2022 Jan;43:101230
pubmed: 34927038
Clin Infect Dis. 2023 Feb 18;76(4):620-630
pubmed: 36208211

Auteurs

Joshua M Chevalier (JM)

Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Alvin X Han (AX)

Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Megan A Hansen (MA)

Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Ethan Klock (E)

Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.

Hiromi Pandithakoralage (H)

Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.

Tom Ockhuisen (T)

Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Sarah J Girdwood (SJ)

FIND, Geneva, Switzerland.

Nkgomeleng A Lekodeba (NA)

Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Alexandra de Nooy (A)

Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Shaukat Khan (S)

FIND, Geneva, Switzerland.

Cheryl C Johnson (CC)

HIV Department, World Health Organization, Geneva, Switzerland.

Jilian A Sacks (JA)

Department of Epidemic and Pandemic Preparedness and Prevention, World Health Organization, Geneva, Switzerland.

Helen E Jenkins (HE)

Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.

Colin A Russell (CA)

Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Brooke E Nichols (BE)

Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands brooke.nichols@finddx.org.
Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
FIND, Geneva, Switzerland.
Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH